Laura Sutcliffe
Stock Analyst at UBS
(1.55)
# 3,219
Out of 4,837 analysts
6
Total ratings
66.67%
Success rate
-2.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Buy | $290 → $285 | $248.14 | +14.85% | 1 | Apr 24, 2025 | |
| TLX Telix Pharmaceuticals | Maintains: Buy | $21 → $22 | $16.44 | +33.82% | 2 | Jan 27, 2025 | |
| ARGX argenx SE | Initiates: Buy | $390 | $578.31 | -32.56% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $28.90 | - | 2 | Dec 20, 2019 |
ResMed
Apr 24, 2025
Maintains: Buy
Price Target: $290 → $285
Current: $248.14
Upside: +14.85%
Telix Pharmaceuticals
Jan 27, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $16.44
Upside: +33.82%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $578.31
Upside: -32.56%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $28.90
Upside: -